This budget analysis reviews U.S. funding for global health programs included in the fiscal year 2015 Budget Request released on March 4, 2014. It examines funding by program area as well as trends over time.
- state & global data
- view as grid
- view as list
The 2013 Survey of Americans on the U.S. Role in Global Health examines the American public’s views, knowledge and opinions of U.S. efforts to improve health for people in developing countries. The fifth in a series that began in 2009, the survey explores the public’s views on global health spending and foreign aid, their priorities for the U.S. in world affairs, and the attention they pay to the issue of health in developing countries.
Sustaining Medicare for the Future: What’s Next In the Debt-Reduction Debate? Briefing and Panel Discussion
As Washington continues to search for long-term solutions to reduce federal spending, with Medicare often at the forefront of these discussions, the Kaiser Family Foundation held a policy briefing Wednesday, Jan. 30, at 9:30 a.m. to explore options that could be considered to reduce Medicare spending, and their implications for…
In his latest column for The Wall Street Journal’s Think Tank, Drew Altman dives into this week’s release of the Social Security and Medicare Trustees Report to discuss the good news that may have been missed.
In his latest column for The Wall Street Journal’s Think Tank, Drew Altman dives into this week’s release of the Social Security and Medicare Trustees Report to discuss the good news that may have been missed. All previous columns by Drew Altman are available online.
This report examines a new measure of Medicare’s financial health established by the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (MMA). The report, authored by Marilyn Moon, takes an in-depth look at the program’s new solvency test, which measures general revenues as a share of total Medicare spending and can trigger a “funding warning” that compels the President to propose and the Congress to consider a funding warning.
This blog post discusses Sovaldi (sofosbuvir), an oral drug recently approved by the FDA for the treatment of chronic hepatitis C, and the potential impact of this long-awaited cure on Medicare spending and Part D premiums.
This Policy Insight outlines eight questions that are likely to shape the U.S. global health response in the last two years of the current presidential term and beyond.
In the latest post in the Policy Insights series, Jen Kates and Josh Michaud outline eight questions that are likely to shape the U.S. global health response in the last two years of the current presidential term and beyond. Follow Jen Kates and Josh Michaud on Twitter, and access previous columns…
This paper identifies and quantifies, to the extent possible, the factors that explain the gap between actual Medicare spending in 2014 and CBO’s 2009 projections of what Medicare spending would be this year. The study synthesizes information from a variety of sources and presents new analysis to assess the extent to which lower-than-projected Medicare spending in 2014 can be explained by deliberate policy and program changes, unexpected trends, and other factors.